Overview

Lovastatin for Treatment of Brain Arteriovenous Malformations

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate the disease-modifying efficacy of lovastatin in patients with brain arteriovenous malformation.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Tiantan Hospital
Treatments:
Dihydromevinolin
L 647318
Lovastatin